Relapse after cessation of weekly tocilizumab for giant cell arteritis: a multicentre service evaluation in England. (2023)
Attributed to:
MICA: Treatment According to Response in Giant cEll arTeritis (TARGET)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/kead604
PubMed Identifier: 37952183
Publication URI: http://europepmc.org/abstract/MED/37952183
Type: Journal Article/Review
Parent Publication: Rheumatology (Oxford, England)
ISSN: 1462-0324